GeneDx Holdings (WGS) Faces Securities Class Action After 49% Drop, 94% Write-off Related to Fabric Genomics Acquisition - Hagens Berman

Impact · against what's priced in

GeneDx faces a severe valuation reset following a near-total write-off of its Fabric Genomics acquisition and significant downward revisions to 2026 revenue guidance. The emergence of a securities class action lawsuit adds legal and regulatory risk to an already deteriorating operational profile.

WGS−0.90

No priced-in read yet